Oncogenex Pharmaceuticals Inc (OGXI) - Financial and Strategic SWOT Analysis Review

  • ID: 4278870
  • SWOT Analysis
  • 25 pages
  • GlobalData
  • OncoGenex Pharmaceuticals Inc
1 of 4

Oncogenex Pharmaceuticals Inc (OncoGenex) formerly known as Sonus Pharmaceuticals Inc, is a drug discovery and development company that develops and commercializes therapies and mechaisms for addressing treatment resistance in cancer patients. The company’s products include custirsen and apatorsen. Its custirsen drug is designed to block the production of clusterin, a cytoprotective protein which is upregulated in tumor cells in response to treatment interventions such as chemotherapy, hormone ablation and radiation therapy and is used to treat various cancers including prostate, lung, pancreatic, breast and bladder cancer. OncoGenex’s apatorsen drug is designed to inhibit the production of Hsp27, a protein that is elevated in many cancers and that has been shown to promote cancer cell growth and tumor metastasis. The company partners with many universities and cancer researchers. OncoGenex is headquartered in Bothell, Washington, the US.

Oncogenex Pharmaceuticals Inc Key Recent Developments

May 15, 2017: OncoGenex Pharmaceuticals Reports Financial Results for First Quarter 2017
Feb 23, 2017: OncoGenex Pharmaceuticals Reports Financial Results for Year End 2016

This comprehensive SWOT profile of Oncogenex Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Oncogenex Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Oncogenex Pharmaceuticals Inc - Key Information
  • Oncogenex Pharmaceuticals Inc - Overview
  • Oncogenex Pharmaceuticals Inc - Key Employees
  • Oncogenex Pharmaceuticals Inc - Key Employee Biographies
  • Oncogenex Pharmaceuticals Inc - Key Operational Heads
  • Oncogenex Pharmaceuticals Inc - Major Products and Services
  • Oncogenex Pharmaceuticals Inc - History
  • Oncogenex Pharmaceuticals Inc - Company Statement
  • Oncogenex Pharmaceuticals Inc - Locations And Subsidiaries
  • Oncogenex Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Oncogenex Pharmaceuticals Inc - Business Description
  • Oncogenex Pharmaceuticals Inc - Corporate Strategy
  • Oncogenex Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Oncogenex Pharmaceuticals Inc - Strengths
  • Oncogenex Pharmaceuticals Inc - Weaknesses
  • Oncogenex Pharmaceuticals Inc - Opportunities
  • Oncogenex Pharmaceuticals Inc - Threats
  • Oncogenex Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Oncogenex Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Oncogenex Pharmaceuticals Inc, Key Information
  • Oncogenex Pharmaceuticals Inc, Key Ratios
  • Oncogenex Pharmaceuticals Inc, Share Data
  • Oncogenex Pharmaceuticals Inc, Major Products and Services
  • Oncogenex Pharmaceuticals Inc, History
  • Oncogenex Pharmaceuticals Inc, Key Employees
  • Oncogenex Pharmaceuticals Inc, Key Employee Biographies
  • Oncogenex Pharmaceuticals Inc, Key Operational Heads
  • Oncogenex Pharmaceuticals Inc, Other Locations
  • Oncogenex Pharmaceuticals Inc, Subsidiaries
  • Oncogenex Pharmaceuticals Inc, Key Manufacturing facilities
  • Oncogenex Pharmaceuticals Inc, Key Competitors
  • Oncogenex Pharmaceuticals Inc, SWOT Analysis
  • Oncogenex Pharmaceuticals Inc, Ratios based on current share price
  • Oncogenex Pharmaceuticals Inc, Annual Ratios
  • Oncogenex Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Oncogenex Pharmaceuticals Inc, Performance Chart
  • Oncogenex Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown